# Estimation of the Percentage of US Patients With Cancer Who Are Eligible for Immune Checkpoint Inhibitor Drugs

Article · Haslam A, Gill J, Prasad V

- Archive id: doi:10.1001/jamanetworkopen.2020.0423
- Published: 2020-03-02
- Venue: JAMA network open
- DOI: https://doi.org/10.1001/jamanetworkopen.2020.0423
- PMID: 32150268
- PMCID: PMC7063495
- Citations: 248
- Source URL: https://doi.org/10.1001/jamanetworkopen.2020.0423
- PDF: https://europepmc.org/articles/PMC7063495/pdf
- Provenance: europepmc

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.